News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Finance
SoCal's Amplyx Bags $49.2 Million and Beefs Up Executive Team 2/9/2016
Via Surgical Rakes in $6 Million 2/8/2016
Unilife  (UNIS) To Release Financial Results For The Second Quarter Of Fiscal Year 2016 On February 9, 2016 2/8/2016
Four Big Dividend Pharma Stocks to Buy that are Cheap Now 2/8/2016
Revitope Oncology, Inc. Raises $8.5 Million To Continue Development Of Novel Cancer Immunotherapy Platform 2/8/2016
Biogen (BIIB) Points Out Three New Risk Factors For 2016 in SEC Filing, Report Shows 2/8/2016
Why Celgene (CELG) and Gilead (GILD) Stock Can Jump 30% This Year 2/8/2016
CytRx Corporation (CYTR) Secures $40 Million Long-Term Loan Facility 2/8/2016
Cellular Biomedicine Group (CBMG) Lands $43 Million From Wuhan Dangdai 2/8/2016
Velano Vascular Raises Additional $3.5 Million To Support Further Development and Initial Commercialization of Innovative Blood Draw Device 2/8/2016
Vestagen Nabs $7 Million and a New CEO 2/8/2016
Affinivax Secures Additional Funding To Advance Its Novel Pneumococcal Vaccine Towards Clinical Trials 2/5/2016
Edwards Lifesciences (EW) Announces $325 Million Accelerated Share Repurchase 2/5/2016
Tivorsan Pharmaceuticals, Inc. Closes Private Placement 2/5/2016
Regeneron (REGN) Stock Rocks, but Vertex (VRTX), Medivation (MDVN) & Jazz Pharma (JAZZ) Roll 2/4/2016
Imperial Innovations Placing To Raise £100 Million 2/4/2016
Tribogenics Receives Strategic Investment From Nikon Corporation (NINOF.PK) 2/4/2016
HD Medical Secures Strategic Investment From Maxim Ventures 2/4/2016
Aira.IO Closes $2.5 Million Series A Financing To Deliver Intelligent Assistive Technology 2/4/2016
Epibiome Secures $6 Million Series A Financing To Develop Alternatives To Small-Molecule Antibiotics For Agriculture 2/4/2016
Pioneer Pear Therapeutics Raises $20 Million 2/4/2016
Startup LAM Therapeutics Nabs $40 Million and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer 2/3/2016
Three Biotech Stocks You Don't Have to Constantly Monitor 2/3/2016
Galera Ups Series B Financing to $42 Million 2/3/2016
BioDirection Closes $4 Million Series B Financing 2/3/2016
JustRight Surgical Lands $4.2 Million In Additional Funding, $7 Million In Debt Financing To Close Series B Round 2/3/2016
Enyo Pharma Announces Closing Of A €22 Million Funding Round 2/3/2016
Silk Therapeutics Raises $6 Million In Series A2 Financing 2/3/2016
Mission Therapeutics Snags $86.37 Million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform 2/2/2016
GlaxoSmithKline (GSK) and Johnson & Johnson (JNJ)-Backed VC Firm Medicxi Launches $250 Million Fund for Life Science Startups 2/2/2016
Spero Announces $30 Million Series B Preferred Financing 2/2/2016
Catalent (CTLT) Invests $4.6 Million To Further Expand Asia--Pacific Clinical Trials Hub In Singapore 2/2/2016
Confo Therapeutics Secures €6.7 Million In First Financing Round 2/2/2016
Repositive Secures Further Seed Funding 2/2/2016
With Almost $200 Million in the Bank, WAVE Life Sciences (WVE) Plans Six Clinical Programs in Three Years 2/1/2016
Premier Biomedical Announces Intended $6 Million Investment By Brazilian Joint Venture Partner, Auramedi, To Manufacture, Market And Distribute Premier’s New Technology Products 2/1/2016
Nordic Nanovector Awarded NOK 15 Million From The Research Council Of Norway To Research And Develop Novel Targeted Therapeutics 2/1/2016
Acelity Announces Proposed Private Offering Of $400 Million Of First Lien Senior Secured Notes 2/1/2016
CytoSorbents, Inc. Receives $325,000 In Non-Dilutive Funding From The New Jersey Technology Business Tax Certificate Transfer Program 2/1/2016
Novavax (NVAX) Announces Closing Of $300 Million Offering Of Convertible Senior Notes Due 2023 2/1/2016
Vascular Flow Technologies Gets a $14.3 Million Shot in the Arm 1/29/2016
Amarantus BioSciences Announces $1M Investment 1/28/2016
Adagene Raises $28 Million in Series B Funding 1/28/2016
Two Small Biotechs That May Have a Big 2016 1/28/2016
Investors Grin Over Biogen (BIIB)'s $3.4 Billion Cash Pile and Earnings Report 1/28/2016
Pershing Square’s Bill Ackman Writes Letter of Apology to Investors, Regrets Investing so Heavily into Valeant (VRX) 1/28/2016
Biotech 2016: Now Starts the Hangover 1/28/2016
Aprecia Set To Advance 3D Printed Drug Pipeline With Completion Of $35 Million Financing Led By Deerfield Management 1/27/2016
Neurotrack Secures $6.5 Million In Financing To Advance Cognitive Health 1/27/2016
COSMOSID Raises $6 Million In Series B Funding 1/27/2016
The Bay Area's Secretive Adicet Bio Raises $51 Million and Buys Israel-based Applied Immune Technologies 1/27/2016
Blend Therapeutics Transforms into Tarveda Therapeutics and Bags $38 Million 1/27/2016
Former Biogen (BIIB) Exec's Startup Codiak BioSciences Bags Another $61 Million, Totaling $92 Million for Exosome Research 1/26/2016
World's Richest Doctor's Startup NantCell Rakes in Another $57 Million 1/26/2016
Halozyme (HALO) Announces Closing Of $150 Million Royalty-Backed Debt Financing 1/26/2016
Emmaus Life Sciences Secures Funding To Advance Sickle Cell Disease Treatment 1/26/2016
Minnetronix, Inc. Raises $20 Million In Equity Capital To Support Growth Initiatives 1/26/2016
Enzo Biochem (ENZ) Collects $7 Million From Court Approved Escrow Fund Closings 1/26/2016
Bay Area's Jan Medical Grabs $7.5 Million from Brainlab 1/25/2016
Novavax (NVAX) Announces Proposed Offering Of $200 Million Of Convertible Senior Notes Due 2023 1/25/2016
Moberg Pharma AB (Formerly known as Moberg Derma) Issues A Bond Loan In The Amount Of SEK 300 Million On The Nordic Bond Market To Finance Growth And Acquisitions 1/25/2016
CARsgen Therapeutics Completes $30 Million Series B Financing 1/25/2016
After Restructuring that Includes 25% Employee Reduction, Bay Area's StemCells (STEM) CEO Given $1 Million Severance 1/22/2016
PureTech Health plc Release: Operating Company Akili Interactive Labs Raises $30.5 Million To Advance Product Development And Build Commercial Infrastructure 1/22/2016
Digital Medicine Company Akili Interactive Labs Banks $30.5 Million 1/22/2016
iCarbonX Raises $106 Million In Series A For Big Health Data 1/22/2016
Georgia Bio Deals Of The Year Spotlight Financings, Acquisitions And Collaboration 1/22/2016
Where Pfizer (PFE)-Allergan (AGN) May Be 10 Years Down the Road 1/22/2016
AbbVie (ABBV) CEO Argues Value of Company’s Pipeline, Piques Analysts Interest 1/21/2016
Abingworth Raises $105 Million For First Dedicated Clinical Co-Development Fund 1/21/2016
SoCal's bioTheranostics Rakes In $32 Million for Cancer Diagnostics 1/21/2016
Bay Area's Biodesy Snags $10 Million Series B to Accelerate Commercialization of Next-Gen Protein Analysis Technology 1/21/2016
vasopharm BIOTECH GmbH Announces EUR 20 Million Fundraising To Progress Treatment For Traumatic Brain Injury 1/21/2016
Minnesota’s Medical Alley Raises Record-Setting $434.9 Million In 2015 1/21/2016
Bay Area's Twist Bioscience Locks Up $61 Million Series D, $20 Million Debt Facility 1/20/2016
$100 Million Gift For The New York Genome Center - James H. Simons, PhD, And Russell L. Carson Make Transformational Joint Gift 1/20/2016
Parnell Pharmaceuticals Holdings Announces Agreement With Lincoln Park Captial Fund To Purchase Ordinary Shares 1/20/2016
iCo Therapeutics Terminates Employees in Radical Restructuring Move 1/19/2016
Insulet (PODD) Raises Funds For Continued Diabetes Research 1/19/2016
CASI Pharmaceuticals  (CASI) Announces Initial Closing Of Its Strategic Financing With Receipt Of $10.3 Million Proceeds 1/19/2016
ZipLine Medical Bags $19 Million Financing Led by New Investor, MVM Life Science Partners 1/19/2016
Great Basin Scientific Announces Update Of Series C Warrant Conversions 1/19/2016
Zivo Bioscience, Inc. Executes Debt Restructure/Extension With Primary Lender, Expands Credit Line 1/19/2016
HiberGene Closes First Tranche Of Series B Financing 1/19/2016
4G Clinical Raises $2.5M In Series A Funding 1/19/2016
Mucosis B.V. Secures €3.7M From Wellcome Trust To Fund Clinical Trials Of Its Respiratory Syncytial Virus Vaccine In Partnership With Imperial College London 1/19/2016
Reasons Pfizer (PFE) is a Bargain Now and Why It Doesn’t Want to be Known as Pfizer 1/19/2016
Theracos Snags $25 Million for Diabetes Drug 1/18/2016
Potentially Transformative Therapy For Pulmonary Arterial Hypertension To Be Progressed By Morphogen-IX 1/18/2016
Key Points Amgen (AMGN) CEO Bob Bradway Made at J.P. Morgan 1/15/2016
The New York Genome Center Awarded $40 Million From The NIH To Use Genomic Sequencing To Explore Common Disease 1/15/2016
Actuated Medical, ENTvantage Diagnostics Snag Seed Funding for Pediatric Med Devices 1/15/2016
Hooper Holmes Announces $12 Million Extension To Clinical Study Program 1/15/2016
Pfizer (PFE) and Allergan (AGN) Execs Emphasize Joint Company’s Pipeline, Hint Job Cuts Will Be Minimal 1/14/2016
GE Healthcare, Fedev Ontario Commit CAD $40M For New CCRM-Led Centre To Solve Cell Therapy Manufacturing Challenges 1/13/2016
Apricus Biosciences (APRI) Announces $10 Million Registered Direct Offering 1/13/2016
Sofinnova Ventures Spinout HealthQuest Eyes $175 Million 1/13/2016
Tmunity Therapeutics, Inc. To Advance IND-Enabling Activities For Personalized Next-Generation Engineered T Cell Therapies With $10 Million Financing 1/13/2016
Tiziana Life Sciences Plc Release: Fund Raising 1/13/2016
Propanc Receives Additional $525,000 From Institutional Investor; Initiates Animal Safety Toxicology Studies For PRP 1/13/2016
Syros Pharmaceuticals Closes $40 Million Preferred Stock Financing 1/13/2016
Epizyme (EPZM) Announces Closing Of Public Offering Of Common Stock 1/13/2016
Gilead (GILD) Should Have Investors Giddy Over Continued HCV Dominance at J.P. Morgan 1/13/2016
Bay Area's Kodiak Sciences Rakes in $34 Million to Fuel Retina Pipeline 1/12/2016
Roche (RHHBY) is Favored Stock at J.P. Morgan Conference, Although Investors Remain Unmoved 1/12/2016
Illumina (ILMN) Raises $100 Million with Amazon (AMZN)’s Bezos, Bill Gates and Others to Launch Pan-Cancer Test Company Grail 1/12/2016
ZipLine Medical Snags $16.4 Million 1/12/2016
Accuracy Closes $70 Million Straight Debt Financing 1/12/2016
Corsair Innovations Receives $250,000 In Head Health Challenge Funding For Its Novel FEAM Material 1/12/2016
NovImmune SA Completes CHF30 Million ($29.8 Million) Funding Round With Existing Shareholders 1/12/2016
Pfizer (PFE) Pumps $46 Million into Four Early-Stage Drug Firms 1/11/2016
Martin Shkreli Used $45 Million E-Trade Account as Security to Get Out of Jail 1/11/2016
Cardiorentis Bags $60 Million and Adds Two Key Senior Execs to the Roster 1/11/2016
V-Wave Snags $28 Million Series B Financing 1/11/2016
BioAtla Nabs $45 Million Funding Commitment From U.S. Investment Fund 1/11/2016
CartiHeal Bags $15 Million 1/11/2016
California Life Sciences Association Applauds Gov. Brown On Budget That Invests $10 Million In Precision Medicine Research 1/11/2016
Zai Lab Raises $100+ Million In A Series B Funding 1/11/2016
Bruin Biometrics Completes $9 Million Series A Financing 1/11/2016
EYE TECH CARE Secures $25 Million and a Partnership with EVERPINE Capital 1/11/2016
Aelix Therapeutics Completes Series A Funding Of €11.5M ($12.7M) For Therapeutic HIV Vaccine 1/11/2016
Pressure BioSciences, Inc. (BBII) Exceeds $5 Million PIPE Goal And Opens $1.25 Million Over-Subscription Amount 1/11/2016
Accelerator Launches Lodo Therapeutics With $17 Million Series A To Develop Therapies Derived From Natural Products 1/11/2016
AiCure's Artificial Intelligence Platform Draws $12.25 Million Series A 1/11/2016
SSF's Iconic Therapeutics Closes $40 Million Series C Financing 1/11/2016
Zymeworks Banks $61.5 Million Series A 1/8/2016
EICOSIS, LLC Receives $4 Million To Develop Novel Treatment For Diabetic Neuropathic Pain 1/8/2016
Star Investor Neil Woodford Pushes for GlaxoSmithKline (GSK) to Split Up—Again 1/8/2016
WuXi AppTec Plans $120 Million Investment In New Integrated Biologics Solution Center To Expedite Biologics Development From Ideas To Clinic 1/8/2016
InSightec Secures $22 Million and Appoints Board Chair as CEO 1/8/2016
Bruin Biometrics Completes $9 Million Series A Financing 1/8/2016
BGI Expands Investment In SMRT Sequencing Technology For Its Global Service Business 1/8/2016
BioLargo, Inc. (BLGO.PK) Secures Financing For Its Advanced Wound Care Products Targeting FDA Application, Approval And Commercialization Through Its Subsidiary Clyra Medical Technologies 1/8/2016
Omeros Corporation (OMER) Announces $70 Million New Credit Facility And Conversion Of Contract Sales Force To In-House Team 1/7/2016
Bay Area's Guardant Health Snags $100 Million for Its Radical Approach to Treat Cancer 1/7/2016
Xeris Pharmaceuticals Scores $41 Million Series C Financing 1/7/2016
Exosome Diagnostics Banks $60 Million Series B Financing 1/7/2016
After Restructuring in 2015, TRANSGENE (ENX:TNG) Enters New Phase in Its Strategic Development 1/7/2016
BiO2 Medical Reports Positive Advancement Of The Series D Round Of Funding 1/7/2016
Elastagen Completes A$13m Series B Equity Financing 1/7/2016
Ontario Institute for Cancer Research Invests $1.2 Million To Support Oncology Drug Development In Ontario 1/7/2016
ASLAN Pharmaceuticals Pte Ltd Announces Final Close Of U.S.$43 Million Series C Round 1/7/2016
PierianDx Closes Series A Financing Led By Health Catalyst Capital Management 1/7/2016
IQuity Labs Secures $2 Million In Seed Funding 1/7/2016
Circle Pharma Announces Receipt Of Additional Seed Investment, Relocation To New Laboratory Facility And Initiation Of Internal Pipeline Development 1/7/2016
NovaBay (NBY) Secures $3 Million Bridge Loan 1/7/2016
Alector Announces Closing Of Series D Financing 1/7/2016
Pi-Cardia Completes $10M Financing 1/7/2016
New Year, New Startup C4 Therapeutics Launches with $73 Million Series A Financing 1/7/2016
NextCure, New Immuno-Oncology Firm, Announces $67 Million Series A Financing 1/7/2016
Big Shot Biotechs Like Eli Lilly (LLY), Pfizer (PFE), Johnson & Johnson (JNJ), and AbbVie (ABBV) Bet $48 Million on Startup Petra Pharma 1/7/2016
Why Biogen (BIIB) Lost $2.4 Billion in Two Hours on Monday 1/6/2016
Newly Named Millendo Therapeutics Snags $62 Million in Venture Funding and Buys AstraZeneca PLC (AZN) Drug 1/6/2016
Vivex Biomedical Gets $6.6M for Next-Gen Implant Tech 1/6/2016
Bay Area's Benvenue Medical Nabs $60 Million 1/6/2016
Elastagen Pty Limited Completes A $13 Million Series B Equity Financing 1/6/2016
ESSA Pharma Announces Proposed US$15 Million Private Placement 1/6/2016
Neovasc (NVC) Secures EUR5 Million From The Public Funding Program «Investments For The Future» To Support Clinical And Industrial Development For The Therapeutic Vaccine Infa Kinoïd 1/6/2016
Pathway Genomics Bags $40 Million 1/6/2016
Cortexyme Raises $15 Million Series A 1/6/2016
GlySens Secures $20 Million Series D 1/5/2016
Premier Biomedical Announces $1.6 Million Financing – Consolidates Funding Needs Through 2016 1/5/2016
Entac Medical Announces Funding Of Series A Round 1/5/2016
Deciphera Increases Size Of Series B Financing To Over $90 Million With Addition Of SV Life Sciences 1/5/2016
Ortho Kinematics Raises $4 Million In Debt Financing 1/5/2016
Massachusetts Startup Scholar Rock Scores $36 Million to Move Drug to First Clinical Trial 1/5/2016
The Worst Three Performing Biotech Stocks for 2015 1/4/2016
Helius Medical Technologies Announces Receipt Of Remainder Of A&B Funding, Changes To Board Of Directors, And Extension Of CRADA Agreement Through December 2017 1/4/2016
Emperra Digital Diabetes Care Closes Series B Round With Robert Bosch Venture Capital Gmbh Joining As A New Investor 1/4/2016
Martin Shkreli's Former Drugmaker KaloBios (KBIO) Files for Bankruptcy 1/4/2016
ReWalk (RWLK) Secures Line of Credit of Up to $20 Million to Support Market Building Activities 1/4/2016
Zipnosis Announces $17 Million Series A Financing Led By Safeguard Scientifics (SFE) 1/4/2016
Nymox Pharmaceutical (NYMX) Files Current Financial Statements 1/4/2016
Halozyme (HALO) Enters Into Agreement For $150 Million Non-Dilutive Royalty-Backed Debt Financing 1/4/2016
Five Massachusetts Biotech Companies Show Big Stock Gains This Year 12/31/2015
Hemispherx (HEB) Boss Returns Shares After Stock Snafu 12/31/2015
KaloBios (KBIO) Notified By Nasdaq Stock Market Of Additional Bases For Delisting 12/31/2015
Medifocus Announces Grant Of Incentive Options And Completion Of Shares For Debt Transaction 12/31/2015
Bioniz Therapeutics $15 Million Fundraising 12/31/2015
Will Merck & Co. (MRK) Raise Its Dividend In 2016? 12/31/2015
Will Amgen (AMGN) Raise Its Dividend In 2016? 12/31/2015
BioTime (BTX) Completes Distribution Of Approximately 4.75 Million Shares Of OncoCyte Corporation Common Stock 12/31/2015
Kane Biotech Inc. (KNE) Announces Issuance Of Common Shares In Payment Of Outstanding Interest 12/31/2015
Hedge Fund Manager Steven Cohen Reports 5.3% Stake in Chimerix (CMRX) 12/31/2015
Anteo Diagnostics In ASX Trading Halt 12/31/2015
Orchid Pharma Stock Surges On U.S. FDA Inspection Report For TN Unit 12/31/2015
Binational Industrial R&D Foundation To Invest $7.5 Million In 9 New Projects 12/30/2015
SeaSpine Announces $30 Million Credit Facility With Wells Fargo Capital Finance 12/30/2015
Third Independent Proxy Advisory Firm Recommends That Puma Biotech (PBYI) Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card 12/30/2015
NeuroMetrix (NURO) Announces $13.8 Million At The Market Private Placement Of Preferred Stock And Warrants 12/30/2015
eyeBrain Medical Pulls In $6 Million For Neurolens Chronic Headache Treatment 12/30/2015
Anavex (AVXL) Shares Plummet After Company Discloses SEC Investigation and Subpoena 12/30/2015
Great Basin Scientific Secures $20.5 Million Funding Commitment In Senior Convertible Notes 12/29/2015
Orgenesis Note Holders Elect To Convert $950,000 Of Outstanding Notes 12/29/2015
Lone Star Value Issues Statement To Fellow Enzo Biochem (ENZ) Shareholders 12/29/2015
Second Leading Independent Proxy Advisory Firm Recommends That Puma Biotech (PBYI) Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card 12/29/2015
NW Bio (NWBO) Announces Closing Of Registered Direct Offering Of $12.6 Million 12/28/2015
Anpac Bio-Medical Science Receives "Series B" Funding From Shanghai Zhangjiang Science & Technology Investment Corp & Private Insurance Investors 12/28/2015
Relmada Therapeutics Recommends Stockholders Vote "FOR" Relmada's Director Nominees on the WHITE Proxy Card Today 12/28/2015
Nohla Therapeutics Closes Oversubscribed U.S. $21M Private Financing Round And Strengthens Board With New Appointment 12/28/2015